Accessibility Menu
Telesis Bio logo

Telesis Bio

(OTC) TBIO

Current Price$0.05
Market Cap$3.92M
Since IPO (2021)-100%
5 Year-100%
1 Year-83%
1 Month-6%

Telesis Bio Financials at a Glance

Market Cap

$3.92M

Revenue (TTM)

$13.53M

Net Income (TTM)

-$45.55M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-13.73 (Low)

Price

$0.05

Volume

177

Open

$0.05

Previous Close

$0.05

Daily Range

$0.05 - $0.05

52-Week Range

$0.00 - $0.30

Estimated Earnings Date

Aug 6, 2026

TBIO News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Telesis Bio

Industry

Life Sciences Tools and Services

Employees

39

CEO

Eric Esser

Headquarters

Lexington, MA 92121-2993, US

TBIO Financials

Key Financial Metrics (TTM)

Gross Margin

61.62%

Operating Margin

-169.18%

Net Income Margin

-173.49%

Return on Equity

-125.42%

Return on Capital

-72.81%

Return on Assets

-67.78%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.92M

Shares Outstanding

78.39M

Volume

177

Avg. Volume

505.871

Financials (TTM)

Gross Profit

$4.58M

Operating Income

-$30.56M

EBITDA

-$38.48M

Operating Cash Flow

-$22.85M

Capital Expenditure

-$890.00K

Free Cash Flow

-$23.74M

Cash & ST Invst.

$4.51M

Total Debt

$16.29M

Telesis Bio Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2024YOY CHG

Revenue

$1.57M

-71.9%

Gross Profit

$1.01M

-66.3%

Gross Margin

64.43%

N/A

Market Cap

$3.92M

N/A

Market Cap/Employee

$100.51K

N/A

Employees

39

N/A

Net Income

-$6.64M

+37.5%

EBITDA

-$4.68M

+48.7%

Quarterly Fundamentals

Name
Q3 2024YOY CHG

Total Cash

$4.51M

-89.1%

Total Debt

$16.29M

-67.4%

Accounts Receivable

$1.26M

-76.4%

Inventory

$1.10M

-74.3%

Long Term Debt

$14.09M

-57.3%

Short Term Debt

$4.41M

-74.0%

Return on Assets

-67.78%

N/A

Return on Invested Capital

-74.79%

N/A

Free Cash Flow

-$7.01M

-17.1%

Operating Cash Flow

-$6.96M

-18.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CYDXCYduct Diagnostics, Inc.
$0.42+0.00%
MAHNMid-Atlantic Home Health Network, Inc.
$0.50+0.00%
ESMCEscalon Medical Corp.
$0.19+0.00%
CHMEChina Medicine Corp.
$0.02+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$17.92-0.01%
TAT&T
$20.58+0.00%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.30-0.15%
CLROClearOne
$6.48+1.01%

Questions About TBIO

What is the current price of Telesis Bio?

Telesis Bio is trading at $0.05 per share.

What is the 52-week range for Telesis Bio?

Over the past 52 weeks, Telesis Bio has traded between $0.00 and $0.30.

How much debt does Telesis Bio have?

As of the most recent reporting period, Telesis Bio reported total debt of $16.29M.

How much cash does Telesis Bio have on hand?

Telesis Bio reported $3.82M in cash and cash equivalents in its most recent financial results.

What is Telesis Bio’s dividend yield?

Telesis Bio does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.